MNTAMOMENTA PHARMACEUTICALS INC

Nasdaq www.momentapharma.com


$ 52.49 $ -0.01 (-0.02 %)    

Wednesday, 30-Sep-2020 15:59:13 EDT
QQQ $ 495.80 $ 5.12 (1.04 %)
DIA $ 393.71 $ 0.87 (0.22 %)
SPY $ 554.29 $ 3.18 (0.58 %)
TLT $ 92.56 $ 0.76 (0.83 %)
GLD $ 220.89 $ 2.94 (1.35 %)
$ 52.48
$ 52.10 x 1,000
$ 52.52 x 1,000
-- - --
$ 12.21 - $ 52.53
7,906,162
na
6.24B
$ 1.31
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-10-2020 06-30-2020 10-Q
2 05-07-2020 03-31-2020 10-Q
3 02-27-2020 12-31-2019 10-K
4 11-04-2019 09-30-2019 10-Q
5 08-07-2019 06-30-2019 10-Q
6 05-03-2019 03-31-2019 10-Q
7 02-22-2019 12-31-2018 10-K
8 11-07-2018 09-30-2018 10-Q
9 08-09-2018 06-30-2018 10-Q
10 05-09-2018 03-31-2018 10-Q
11 02-26-2018 12-31-2017 10-K
12 11-01-2017 09-30-2017 10-Q
13 08-04-2017 06-30-2017 10-Q
14 05-05-2017 03-31-2017 10-Q
15 02-24-2017 12-31-2016 10-K
16 11-04-2016 09-30-2016 10-Q
17 08-05-2016 06-30-2016 10-Q
18 05-06-2016 03-31-2016 10-Q
19 02-26-2016 12-31-2015 10-K
20 11-06-2015 09-30-2015 10-Q
21 08-04-2015 06-30-2015 10-Q
22 05-05-2015 03-31-2015 10-Q
23 02-27-2015 12-31-2014 10-K
24 11-07-2014 09-30-2014 10-Q
25 08-04-2014 06-30-2014 10-Q
26 05-06-2014 03-31-2014 10-Q
27 02-28-2014 12-31-2013 10-K
28 11-08-2013 09-30-2013 10-Q
29 08-06-2013 06-30-2013 10-Q
30 05-10-2013 03-31-2013 10-Q
31 02-28-2013 12-31-2012 10-K
32 11-08-2012 09-30-2012 10-Q
33 08-08-2012 06-30-2012 10-Q
34 05-09-2012 03-31-2012 10-Q
35 02-28-2012 12-31-2011 10-K
36 11-08-2011 09-30-2011 10-Q
37 08-05-2011 06-30-2011 10-Q
38 05-05-2011 03-31-2011 10-Q
39 03-10-2011 12-31-2010 10-K
40 11-08-2010 09-30-2010 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 the-daily-biotech-pulse-amag-spikes-on-takeover-rumors-zosano-wilts-on-regulatory-setback-pulmonx-makes-wall-street-debut

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

 the-daily-biotech-pulse-eton-snags-second-fda-nod-for-month-vaccine-updates-from-moderna-curevac

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

Core News & Articles

  Before 10 a.m. ET Tuesday, 59 stocks hit new 52-week highs.

 the-daily-biotech-pulse-fda-nod-for-pfizer-sorrentos-covid-19-antibody-animal-data-orphazymes-wall-street-debut

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

Core News & Articles

  Monday morning saw 39 companies set new 52-week highs.

 the-week-ahead-in-biotech-fda-decisions-for-mesoblast-and-eton-coronavirus-vaccine-updates

Biotech stock reversed course last week, dragged lower by the broader market weakness.

 the-daily-biotech-pulse-moderna-expands-into-switzerland-tiziana-to-spin-off-testing-unit-metacrine-ipo

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15)

Core News & Articles

  Tuesday morning saw 94 companies set new 52-week highs.

Core News & Articles

Momenta Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period in Connection with Proposed Sale to Johnson &a...

 plasma-centric-drugmaker-grifols-to-buy-geriatric-pharma-startup-alkahest

Blood plasma and diagnostics company Grifols SA (NASDAQ: GRFS) is set to completely acquire Alkahest Inc, a biopharmaceutical s...

Core News & Articles

Upgrades

 hc-wainwright--co-downgrades-momenta-pharmaceuticals-to-neutral-announces-525-price-target

HC Wainwright & Co. analyst Douglas Tsao downgrades Momenta Pharmaceuticals (NASDAQ:MNTA) from Buy to Neutral and announ...

 johnson--johnson-borrows-75b-to-fund-its-purchase-of-momenta

Johnson & Johnson (NYSE: JNJ) is borrowing $7.5 billion in bonds to help fund its purchase of Momenta Pharmaceuticals, Inc ...

Core News & Articles

Upgrades

 10-biggest-price-target-changes-for-thursday

RBC Capital raised the price target on NVIDIA Corporation (NASDAQ: NVDA) from $461 to $528. NVIDIA shares fell 0.8% to $481...

 the-daily-biotech-pulse-curevac-close-to-coronavirus-vaccine-deal-with-eu-entera-bios-positive-readout-patent-protection-for-co-diagnostics

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19)

 cantor-fitzgerald-maintains-neutral-on-momenta-pharmaceuticals-raises-price-target-to-525

Cantor Fitzgerald maintains Momenta Pharmaceuticals (NASDAQ:MNTA) with a Neutral and raises the price target from $38 to $52.5.

 truist-securities-downgrades-momenta-pharmaceuticals-to-hold

Truist Securities downgrades Momenta Pharmaceuticals (NASDAQ:MNTA) from Buy to Hold.

 stifel-downgrades-momenta-pharmaceuticals-to-hold-raises-price-target-to-525

Stifel analyst Derek Archila downgrades Momenta Pharmaceuticals (NASDAQ:MNTA) from Buy to Hold and raises the price target f...

 68-biggest-movers-from-yesterday
68 Biggest Movers From Yesterday
08/20/2020 09:07:42

Gainers Blonder Tongue Laboratories, Inc. (NYSE: BDR) shares climbed 77.6% to close at $1.35 on Wednesday after dropping ov...